Page 64 - Journal of Special Operations Medicine - Fall 2014

22. Millner RWJ, Lockhart AS, Marr R. Chitosan arrests 40. Kragh JF Jr, Mann-Salinas EA, Kotwal RS, et al. Labo-
bleeding in major hepatic injuries with clotting dysfunc- ratory assessment of out-of-hospital interventions to
tion: an in vivo experimental study in a model of hepatic control junctional bleeding from the groin in a manikin
injury in the presence of moderate systemic heparinisa- model. Am J Emerg Med. 2013;31:1276–1278.
tion. Ann R Coll Surg Engl. 2010;92:559–561. 41. Kotwal RS, Montgomery HR, Kotwal BM, et al. Elimi-
23. Koksal O, et al. Hemostatic effect of a chitosan linear nating preventable death on the battlefield. Arch Surg.
polymer (Celox) in a severe femoral artery bleeding rat 2011;146:1350–1358.
model under hypothermia or warfarin therapy. Turk J 42. Butler FK, Holcomb JB, Giebner SD, et al. Tactical Com-
Trauma Emerg Surg. 201;17:199–204. bat Casualty Care 2007: evolving concepts. Mil Med
24. Millner RW, Lockhart AS, Marr R, et al. Omni-Stat (Chi- 2007;172:1–19.
tosan) arrests bleeding in heparinised subjects in vivo: an 43. Kheirabadi BS, Edens JW, Terrazas IB, et al. Com-
experimental study in a model of major peripheral vascu- parison of new hemostatic granules/powders with cur-
lar injury. Eur J Cardiothorac Surg. 2011;39:952–954. rently deployed hemostatic products in a lethal model
25. Muzzi L, Tommasino G, Tucci E, et al. Successful use of a of extremity arterial hemorrhage in swine. J Trauma.
military haemostatic agent in patients undergoing extra- 2009;66:316–326.
corporeal circulatory assistance and delayed sternal clo- 44. Kheirabadi BS, Scherer MR, Estep JS, et al. Determina-
sure. Interact Cardiovasc Thorac Surg. 2012;14:695–698. tion of efficacy of new hemostatic dressings in a model of
26. Schmid BC, Rezniczek GA, Rolf N, et al. Postpartum extremity arterial hemorrhage in swine. J Trauma. 2009;
hemorrhage: use of hemostatic combat gauze. Am J Ob- 67:450–459.
stet Gynecol. 2012;206:e12–e13. 45. Arnaud F, Parreno-Sadalan D, Tomori T, et al. Compar-
27. Schmid BC, Rezniczek GA, Rolf N, et al. Uterine packing ison of 10 hemostatic dressings in a groin transsection
with chitosan-covered gauze for control of postpartum model in swine. J Trauma. 2009;67:848–855.
hemorrhage. Am J Obstet Gynecol. 2013;209:225. 46. Arnaud F, Teranishi K, Tomori T, et al. Comparison of 10
28. Tan ECTH, Bleeker CP. Field experience with a chitosan- hemostatic dressings in a groin puncture model in swine.
based haemostatic dressing. Med Corps Int Forum. 2011; J Vasc Surg. 2009;50:632–639.
3:11–15. 47. Butler FK, Giebner S, McSwain N, eds. Prehospital
29. Arul GS, Bowley DM, DiRusso S. The use of Celox gauze trauma life support manual (7th ed, military version). St.
as an adjunct to pelvic packing in otherwise uncontrolla- Louis, MO: Mosby/Elsevier; 2010.
ble pelvic haemorrhage secondary to penetrating trauma. 48. Kheirabadi BS, Mace JE, Terrazas IB, et al. Safety evalu-
J R Army Med Corps. 2012;158:331–333. ation of new hemostatic agents, smectite granules, and
30. Wedmore I, McManus JG, Pusateri AE, et al. A special re- kaolin-coated gauze in a vascular injury wound model in
port on the chitosan-based hemostatic dressing: experience swine. J Trauma. 2010;68:269–277.
in current combat operations. J Trauma. 2006;60:655–658. 49. Bennett, BL, Littlejohn L. Review of third generation top-
31. Pozza M, Millner RWJ. Celox (chitosan) for haemostasis ical hemostatic agents for combat casualty care. Mil Med.
in massive traumatic bleeding: experience in Afghanistan. 2014;179:497.
Eur J Emerg Med. 2011;18:31–33. 50. Singh DK, Ray AR. Biomedical application of chitin, chi-
32. Brown MA, Daya MR, Worley JA. Experience with chi- tosan, and their derivatives. J Macromol Sci Part C Poly-
tosan dressings in a civilian EMS system. J Emerg Med. mer Rev. 2000;40:69–83.
2009;37:1–7. 51. Roberts GAF. Chitin chemistry. London, UK: MacMillan;
33. Eastridge BJ, Mabry R, Seguin P, et al. Death on the battle- 1992.
field (2001–2011): implications for the future of combat ca- 52. Aranaz I, Mengibar N, Harris R, et al. Functional charac-
sualty care. J Trauma Acute Care Surg. 2012;73:S431–S437. terization of chitin and chitosan. Curr Chem Biol. 2009;
34. Kragh JF Jr, Walters TJ, Baer DG, et al. Practical use of 3:203–230.
emergency tourniquets to stop bleeding in major limb 53. Aiba S. Studies on chitosan: 4. Lysozymic hydrolysis of par-
trauma. J Trauma. 2008;64(2 Suppl):S38–S49. tially N-acetylated chitosans. Int J Biol Macromol. 1992;
35. Kragh JF, Walters TJ, Baer DG, et al. Survival with emer- 14:225–228.
gency tourniquet use to stop bleeding in major limb 54. Baldrick P. The safety of chitosan as a pharmaceutical ex-
trauma. Ann Surg. 2009;249:1–7. cipient. Regul Toxicol Pharmacol. 2010;56:290–299.
36. Walters TJ, Wenke JC, Kauvar DS, et al. Effectiveness of 55. Rao SB, Sharma CP. Use of chitosan as a biomaterial:
self-applied tourniquets in human volunteers. Prehosp studies on its safety and hemostatic potential. J Biomed
Emerg Care. 2005;9:416–422. Mater Res. 1997;34:21–28.
37. Pusateri AE, Holcomb JB, Kheirabadi BS, et al. Making 56. Chou TC, Fu E, Wu CF, et al. Chitosan enhances platelet
sense of the preclinical literature on advanced hemostatic adhesion and aggregation. Biochem Biophys Res Com-
products. J Trauma. 2006;60:674–682. mun. 2003;302:480–483.
38. Gordy SD, Rhee P, Schreiber MA. Military applications 57. Watters JM, Van PY, Hamilton GJ, et al. Advanced hemo-
of novel hemostatic devices. Exp Rev Med Dev. 2011; static dressings are not superior to gauze for care under
8:41–47. fire scenarios. J Trauma. 2011;70:1413–1418.
39. Kragh JF Jr, Murphy C, Dubick MA, Baer DG, et al. New 58. Devlin JJ, Kircher SJ, Littlejohn LF. Models for hemostatic
tourniquet device concepts for battlefield hemorrhage agent testing: control versus fidelity. J Trauma. 2009;67:
control. US Army Med Dept J. 2011;Apr–Jun:38–48. 677–678.

56 Journal of Special Operations Medicine Volume 14, Edition 3/Fall 2014